PTGER1: Prostaglandin E2 receptor EP1 subtype
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for prostaglandin E2 (PGE2).
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Alprostadil | Approved | Prostanoid EP1 receptor agonist | Agonist | Boxed warning |
| ONO-8539 | — | Prostanoid EP1 receptor antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Nephrolithiasis
- 0.48
- Urolithiasis
- 0.42
- Ureterolithiasis
- 0.42
- Bladder calculus
- 0.40
- Diabetic foot
- 0.39
- Patent ductus arteriosus
- 0.37
- Cardiovascular disorder
- 0.37
- Neurodegenerative disease
- 0.33
- Premature rupture of membranes
- 0.28
- Fetal growth restriction
- 0.26
- Pain
- 0.26
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- PTGER1
- Related
- Prostaglandin E2 receptor
Drugs and mechanisms are from ChEMBL CHEMBL1811 (CC BY-SA 3.0). Gene name, function (UniProt P34995, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets